PMGC Holdings Inc. Common Stock ELAB

PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

ELAB hizo una agrupación de acciones (split inverso) de 1:10 el 21 de agosto de 2026: cada 10 acciones se juntaron en una. Bajó la cantidad de acciones y subió su precio, pero no el valor total de la inversión.

• GlobeNewswire Inc. 18 sept

  PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings

  PMGC Holdings Inc. (Nasdaq: ELAB) has executed a payment agreement with Longevity Health Holdings to convert its 5% net sales royalty from the January 2025 Elevai Skincare divestiture into scheduled monthly cash payments through August 2031. The agreement covers the 2025 royalty of $94,937 and all future royalty payments, with installments of $10,000 per month starting October 2026, interest accruing at WSJ Prime plus 1%, and mandatory prepayments triggered by capital events.

  

• GlobeNewswire Inc. 25 ago

  PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss

  PMGC Holdings has entered into a non-binding term sheet with Australia-based Orbit2Orbit to conduct a spaceflight study evaluating NorthStrive Biosciences' muscle-preservation therapeutics (EL-22 and EL-32) in microgravity. The multi-part relationship includes a Mice2Space research collaboration, a U.S. aerospace manufacturing partnership with A&B Aerospace, and a planned CAD $200,000 strategic investment by PMGC in Orbit2Orbit ahead of its proposed Canadian Securities Exchange listing.